Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.
作者信息
Hottinger Andreas F, de Micheli Rita, Guido Vanessa, Karampera Alexandra, Hagmann Patric, Du Pasquier Renaud
机构信息
Department of Clinical Neurosciences (A.F.H., V.G., A.K., R.D.P.), Department of Oncology (A.F.H., R.d.M.), and Department of Radiology (P.H.), CHUV University Hospital & University of Lausanne, Switzerland.
出版信息
Neurol Neuroimmunol Neuroinflamm. 2018 Jan 11;5(2):e439. doi: 10.1212/NXI.0000000000000439. eCollection 2018 Mar.
Abstract
摘要
Zotero 插件